EHRA 2023: Late-Breaking Science Video Collection

Published: 18 April 2023

  • Views:

    Views Icon 2152
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice. 

About the episode

EHRA 2023 — Dr Juan Caro Codón (La Paz University Hospital, Madrid, ES) discusses the findings from the TEMPO-HCM study investigating extended ECG monitoring in hypertrophic cardiomyopathy (HCM) patients.  

This was a prospective, observational, multicenter trial that included patients with a diagnosis of hypertrophic cardiomyopathy. Investigators compared the rate of clinically relevant arrhythmias within 30 days vs their first 24 hours with an ECG. 

1. What is the significance of this study and what are the barriers in treating HCM patients?
2. Study design, patient cohort, and outcome measures?
3. Current findings of the study?
4. How should these findings influence practice and guidelines?
5. What are the next steps?

Filmed on-site at EHRA 2023, Barcelona. 

Faculty Biographies

Juan Caro Codón

View full profile


You must be to comment. If you are not registered, you can register here.